A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine. Yilmaz IC, Ipekoglu EM, Golcuklu BS, Bildik T, et al. Vaccine 2025;49:126787.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yilmaz IC, Ipekoglu EM, Golcuklu BS, Bildik T, et al. A phase I/II study of CpG/alum-adjuvanted mammalian-derived quadruple antigen carrying virus-like particle COVID-19 vaccine. Vaccine 2025;49:126787.
PMID: 39892108